 |
|
|
Biotechnology is a biology-based technology revolutionizing fields like agriculture, medicine and food, and bringing new changes everyday, making it difficult to stay updated. We, at RNCOS, work diligently to let clients know the industry closely with our biotech research reports.
We evaluate the market from various perspectives, like by application areas, by geography, and by segment to give an insight into the market.
Our professional experts employ advanced and sophisticated research tools to explore the various application areas of the biotech industry, including Biopharmaceuticals, Agricultural-Biotechnology, and Biogenerics.
We provide intensive statistical and analytical account on the biotech market, its segmented performance, Biotech investments, biotech companies, Biotech parks, and the new avenues being opened by the industry globally, especially Contract Research. We project the future of the biotechnology market to help clients make the decisions best for their business.
 |
| Global Gene Therapy Market Analysis |
| Jun, 2013 | Pages : 110 |
| Global gene therapy market is anticipated to attain exceptional growth with the advent of new drugs in the market and reach to a stupendous mark of US$ 335 Million by 2017-end...
read more |
|
Buy Now
US$ 1200.00
|
|
 |
| Erythropoietin Market Forecast to 2015 |
| Jun, 2012 | Pages : 34 |
| The market EPO has shown a negative trend over the past few years and this trend is expected to continue in future also due to patent expirations and positive desire to opt for biosimilars...
read more |
|
Buy Now
US$ 400.00
|
|
|
|
|
 |
| Interferon Market Forecast to 2015 |
| Jun, 2012 | Pages : 37 |
| The market for interferons (IFN), which have antiviral, anti-proliferative, and immuno-modulatory properties, is expected to cross the US$ 10 Billion-mark by 2015...
read more |
|
Buy Now
US$ 400.00
|
|
|
 |
| G-CSF Biosimilars Market Forecast to 2015 |
| May, 2012 | Pages : 35 |
| It is expected that the patent expiries of Neupogen and Neulasta (pegfilgrastim) will make the way for the entry of G-CSF biosimilars which are anticipated to touch the US$ 350 Million-mark by 2015...
read more |
|
Buy Now
US$ 300.00
|
|
|
|
|
|
|
|
|
|
 |
|
|